Navigation Links
Novel Photoconductive Cellular Depolarization Technology Reveals Insight Into Neuronal Growth, Guidance, and Regeneration
Date:1/30/2009

BOSTON, Jan. 30 /PRNewswire/ -- Neurosilicon's novel Photoconductive Stimulation Device (PSD) was highlighted in the recent scientific publication by Hung and Colicos titled, Astrocytic Ca2+ Waves Guide CNS Growth Cones to Remote Regions of Neuronal Activity. The article appearing in the November 2008 issue of The Public Library of Science One journal focuses on the role of neuronal activity in mediating axonal guidance. It is known that the path axons follow is important in defining neuronal connectivity in the brain. Following an injury, axons must find their way back to their proper targets or find new ones in order to achieve functional recovery. Given this, researchers have sought to better understand how axon guidance is mediated in order to potentially aid in recovery following injury.

Focusing on the affects of action potential induced depolarization, Hung and Colicos sought to extend previous findings and investigate how axonal growth cones respond to actual physiological stimulation in spatially displaced neurons. To do this' they applied photoconductive stimulation technology. One of the strengths of photoconductive stimulation is that it is optically activated and therefore non-invasive, requiring no physical cellular perturbation to elicit depolarization. Additionally, photoconductive stimulation has greater spatial specificity than extracellular field stimulation as well as greater temporal resolution than direct neurotransmitter application. Previously, photoconductive stimulation has been applied to demonstrate activity-driven new synapse formation in cultured neurons while allowing for the dynamic observation of the cellular elements within the neurons. In the current study, the application of photoconductive stimulation induced high frequency action potentials revealing that activity serves as an attractant signal for growth cones. These observations suggest a signaling pathway for activity-dependant axon guidance in which growth guidance both spatial and temporal is mediated by neuronal activity. Further under experimental conditions simulating injury, it was observed that growth cone attraction was not inhibited suggesting that this mechanism could be used to guide neuronal regeneration following axonal injury.

Photoconductive stimulation has enabled researchers to significantly expand the depth, breadth, and complexity of approaches aimed at understanding and addressing areas of unmet neurological healthcare need. This novel technology provides researchers with the means to dynamically study excitation dependent cellular responses without the requirement for a direct physical link to the cell (such as with electrodes in patch clamping or transistor contact necessary in micro electrode arrays). The PSD can also be used in place of pharmacological agonist stimulation, which does not allow for specific cell targeting and/or rapid repetitive depolarization.

About Neurosilicon

Neurosilicon develops novel brain-computing interfaces to expand the scientific understanding of the human brain and to revolutionize and improve the effectiveness of drug discovery. The company's flagship product, the Photoconductive Stimulation Device (PSD) stimulates excitable cells in a precise and controllable fashion. Neurosilicon is comprised of a multidisciplinary team of neuroscientists and engineers working together to advance the boundaries of life science research.

For more information on the (PSD), or to order, please visit http://www.neurosilicon.com


'/>"/>
SOURCE Neurosilicon
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
3. Researchers uncover novel mechanism that balances the sizes of functional areas in the brain
4. Novel Cooling Therapy May Have Aided Injured Football Player
5. ECLIPSE data on effects of Otsukas investigational novel treatment, Tolvaptan
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. GrantAdler Shipping Novel Implantable Vascular Access Port
8. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
9. Novel strategy under study for aggressive leukemia
10. ISTO Technologies Receives 510(k) Clearance for a Novel Bone Graft Substitute and Bone Graft Extender
11. 454 Sequencing(TM): Science Paper Describes a Novel, Highly Efficient Method of Sequencing Ancient DNA; Sequences the Mitochondria of 10 Individual Mammoths to Prove It
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... ... Bellus Medical, a leader in medical aesthetics, recently acquired ... photodynamic cosmetics (PDC). , Allumera® is the first PDC cream specifically formulated to ... minimize the appearance of pores – all with minimal downtime and results that ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... CA (PRWEB) , ... April 25, 2017 , ... ... the addition of predictive analytics to its patient care management module. Using this ... even before a patient has been initiated on continuous positive airway pressure (CPAP), ...
(Date:4/24/2017)... Massachusetts (PRWEB) , ... April 24, 2017 , ... ... will help busy nursing professionals advance their careers. Beginning in the fall of 2017, ... Nursing (BSN) degree in as few as 16 months and for as little as ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Global ... This report on the prostate cancer therapeutics market ... global market. Increasing prevalence of prostate cancer, launch ... in the development of new drugs & therapeutic ... cancer drug due to lesser side effects are ...
(Date:4/19/2017)... 19, 2017  New research provides evidence that an old ... to a study released today that will be presented at ... in Boston , April 22 to 28, ... of Parkinson,s disease, the oral drug levodopa has long been ... But as the disease progresses, the effects of the medication ...
(Date:4/18/2017)... April 18, 2017 Viverae ® , a ... the integration of IBM ® Watson Campaign Automation, ... targeted communications for a personalized experience. Through digital engagement, ... their health in real time. The enhanced experience drives ... to members, wherever they are in their journey to ...
Breaking Medicine Technology: